Abstract: The present invention relates to a method for providing a correction alarm in a continuous biometric information measurement system and, more particularly, to a correction alarm method comprising: calculating the next correction time on the basis of an actual correction time of a user, thereby informing the user of the next correction time calculated on the basis of the actual correction time even if correction is performed differently from that of a preset correction period; and dividing a total use period of time of a sensor into a plurality of correction sections and differently calculating the next correction time on the basis of a correction section, to which a time at which an actual reference biometric value is input belongs, from among the plurality of correction sections, so as to use a reference biometric value input at every correction time, thereby accurately correcting a biometric value.

Abstract: Disclosed herein is a high-strength battery case with improved crack resistance during molding and greater protection against external impact. The battery case may be composed a pouch-type battery case with a pouch film laminate body including a gas barrier layer, a base layer on one surface and a sealant layer on the other surface of the gas barrier layer. At least one cup portion of the battery case can have a recessed shape so as to accommodate an electrode assembly, and a terrace positioned in at least a portion of the circumference of the cup portion. The cup portion may includes a bottom surface and a plurality of circumference surfaces surrounding the bottom surface. A thickness of the gas barrier layer is may be greater than 30 ?m at a corner at which the bottom surface comes in in contact with a pair of circumferences adjacent to each other.

Abstract: The present invention relates to a method for correcting biometric signals in a continuous biometric information measurement system and, more specifically, to a method which, if a correction parameter is unstable when a correction factor is being calculated using a reference biometric value, does not use the current correction factor calculated from a reference biometric value as-is, but revises the current correction factor by applying, to the current correction factor, a compensation value calculated from the difference between the current correction factor and a previous correction factor, and thus even if a correction parameter is unstable it is possible to calculate a corrected biometric value by accurately correcting a biometric signal.

Abstract: The secondary battery includes an electrode assembly to which an electrode lead is attached; a case configured to receive the electrode assembly therein; a lead film configured to surround a part of an outer surface of the electrode lead and interposed between the electrode lead and the case; a vent region formed in at least a part of the case; and a vent member inserted into the vent region and configured to contain linear low-density polyethylene having a poly dispersity index (PDI) of 4 or less, wherein the vent member has a maximum sealing strength of less than 6 kgf/15 mm at 100° C. or above and a maximum sealing strength of 6 kgf/15 mm or more at room temperature to 60° C.

Abstract: Disclosed are an apparatus for treating a substrate and a method of treating a substrate using a supercritical fluid. The apparatus includes: a chamber for providing a treatment space for treating a substrate; and a treatment fluid supply unit for supplying a treatment fluid to the treatment space, in which treatment fluid supply unit includes: a tank for storing the treatment fluid; a heating unit for heating the treatment fluid in the tank to convert the treatment fluid from a first state to a second state; an inlet line for introducing the treatment fluid in the first state into the tank; a supply line for supplying the treatment fluid of the second state from the tank to the chamber; a circulation line for circulating the treatment fluid in the tank; a first valve installed in the circulation line; and a temperature drop member installed in the circulation line to lower a temperature of the treatment fluid flowing through the circulation line.

Abstract: The present technology relates to a reference point marking apparatus for marking reference points on a pattern electrode in which coated portions and uncoated portions are repeatedly arranged in a longitudinal direction, in which the pattern electrode includes a plurality of reserved electrode lane parts to be slit into a plurality of electrode lanes in the longitudinal direction in a subsequent process, and the reference point marking apparatus includes a moving marking machine configured to mark reference points on uncoated portions of the reserved electrode lane parts arranged in a width direction of the pattern electrode while moving in the width direction, and a controller configured to control an operation of the moving 10 marking machine. The present technology also provides a roll map generation apparatus using the reference point marking apparatus.

Abstract: An implantable lead having adjustable electrode locations and a system for controlling the same. The implantable lead may include a plurality of first electrodes exposed and formed at an upper part of a main body at given intervals, a plurality of second electrodes coupled to a stepped lower part of the main body and configured to deliver a stimulus signal to a core area into which the lead is inserted, and a plurality of signal lines embedded in the main body and configured to connect the first electrodes and the second electrodes in a one-to-one manner. In this case, a slot for coupling and up and down movement of the second electrodes may be formed in the lower part. As the second electrodes are individually moved along the slot by an external force acting on the signal lines, locations of the second electrodes in the lower part may be adjusted.

Abstract: The present invention relates to a pouch film laminate body capable of manufacturing a high-strength battery case with excellent resistance to external stress and a battery case manufactured using the same. The pouch film laminate body of the present invention includes a gas barrier layer having a thickness of 60 ?m or greater, a base layer disposed on one surface of the gas barrier layer, and a sealant layer disposed on the other surface of the gas barrier layer. The pouch film laminate layer has a tensile strength of 10 kgf/15 mm to 20 kgf/15 mm in a TD direction and an elongation of 150% to 235% in the TD direction.

Abstract: Systems and methods for manufacturing a battery are disclosed. One system may include: a first cutter configured to cut a first electrode sheet into a first electrode portion; a second cutter configured to cut a second electrode sheet into a second electrode portion having a second length; a winder configured to form an electrode assembly by winding the first electrode portion, the second electrode portion, a separator between the first electrode portion and the second electrode portion; and an identification information assigning device configured to assign identification information to the electrode assembly based on: a cut count value of the first electrode sheet and/or a cut count value of the second electrode sheet; and/or a position coordinate value of the first electrode sheet and/or a position coordinate value of the second electrode sheet.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: A welding device for welding a plurality of materials arranged to be in contact includes a scanner configured to deflect light; a welding laser configured to emit light toward the scanner; a galvo module configured to deflect light toward the scanner; a scan laser configured to emit light toward the galvo module; and a processor configured to control at least one of the scanner and the galvo module to scan boundaries of the plurality of materials.

Abstract: A method of detecting a heart rate using a photoplethysmography (PPG) signal with a removed motion artifact includes receiving, by a heart rate measurement device, a PPG signal and an acceleration signal; converting, by the heart rate measurement device, the PPG signal and the acceleration signal into signals in a frequency domain; calculating, by the heart rate measurement device, a difference between the PPG signal and the acceleration signal in the frequency domain and obtaining a PPG signal with a removed motion artifact; and estimating, by the heart rate measurement device, a heart rate based on the PPG signal with the removed motion artifact.

Abstract: A laser device for skin treatment, includes: a laser generating unit including one or a plurality of diode lasers configured to generate a diode laser pulse, one or a plurality of diode laser drivers each arranged to correspond to the diode laser and configured to vary diode laser pulses generated from the diode laser into pulses having different durations, a laser amplifying unit configured to amplify the pulse transmitted from the diode laser generating unit, and a controller configured to control the diode laser generating unit and the laser amplifying unit to control a wavelength and intensity of a laser output from the laser amplifying unit.

Abstract: The present invention relates to a culture medium composition for culturing keratinocytes, and more specifically, to a culture medium composition for establishing or culturing keratinocytes, comprising calcium, an epidermal growth factor, and albumin According to the present invention, when keratinocytes are cultured using the culture medium of the present invention, the keratinocytes can be effectively proliferated within a short time, thus making it possible to more quickly obtain a desired number of the cells during the development of a therapeutic agent using the keratinocytes, and the activity of the keratinocytes is improved, and thus the culture medium of the present invention can be useful in the fields of keratinocyte research and the development of therapeutic agents.

Abstract: The present invention relates to a culture medium composition obtained by further adding at least one selected from the group consisting of rotenone and albumin to a serum-free medium prepared through a CAMPs technology. It has been ascertained that the proliferation of dermal papilla cells and maintenance of characteristics thereof during culturing can be improved by regulating the concentration of rotenone and albumin, and since the culture medium composition is a serum-free chemical medium comprising no serum, there is no risk of side effects, which can be caused by using a conventional serum medium, during use on the human body. The culture medium composition of the present invention obtained by further adding at least one selected from the group consisting of rotenone and albumin to a serum-free medium, or dermal papilla cells cultured through the composition can be effectively used in the development of therapeutic agents for hair loss prevention and hair growth promotion.

Abstract: A lead implanted in a body to apply electrical stimulation to body organs includes an electrode wire having one end provided as an insertion portion to be inserted into a body and another end provided as an interface portion for connection with an external device; a first electrode in the insertion portion to transmit electrical stimulation to body organs; a second electrode on the interface portion to receive electrical stimulation applied from outside; a signal line that interconnects the first electrode and second electrode to transmit electrical stimulation received by the second electrode to the first electrode; and a ring member that covers the first electrode and has an opening for exposing the first electrode in a portion of a circumferential direction, and is mounted to be movable in a longitudinal or circumferential direction with respect to the electrode wire by an external force to adjust an exposure position of the first electrode.

Abstract: A microelectrode assembly for in vivo neurotransmitter monitoring according to one embodiment of the present disclosure includes: a microelectrode part formed of a single strand; and a polymer coating layer surrounding the microelectrode part, wherein a portion of the microelectrode part may protrude from the polymer coating layer, neurotransmitters in vivo may be sensed by the protruding portion of the microelectrode part, and plasmonic nanostructures may be formed on the surface of the microelectrode part.

Abstract: The present invention relates to: an aqueous (a water-soluble) antiseptic composition having improved antibacterial persistence comprising chlorhexidine or a derivative thereof and a silicon-based emulsifier; and a fabric type antiseptic comprising same. As the chlorhexidine or the derivative thereof is highly soluble and stable and well dispersed in an aqueous phase, the composition can exhibit excellent absorption efficiency when applied onto the skin and can ultimately maximize a cumulative emission amount of chlorhexidine or the derivative thereof. In addition, the use of the polyglyceryl fatty acid ester allows sustained release of chlorhexidine or the derivative thereof, thereby sustaining the antibacterial effect for a long time.

Abstract: The present invention relates to a target gene-detecting device and a method for detecting a target gene. According to an aspect, a target gene-detecting device can be conveniently fabricated at low cost by employing a porous substrate or a method for detecting a target gene allows the pretreatment of a sample, the extraction of a nucleic acid, the amplification of a nucleic acid, and the detection of a target gene to be conducted at high accuracy and specificity in an integral system, with no contamination plausibility and can be thus useful for gene inspection.

Abstract: Disclosed are a point-of-care system and method, the system including: an aptamer-based diagnostic reagent; a diagnostic instrument for detecting a Raman signal through a Raman analysis technique; and a diagnostic kit to be operated on the basis of a lateral flow method, wherein blood and the diagnostic reagent are reacted so as to detect a Raman signal when the placement of the diagnostic kit is detected, thereby allowing the type of acute febrile illness to be identified.